Communiqués TrivarX Limited OTC Markets

Actions

MDBIF

AU0000300196

Produits pharmaceutiques

Marché Fermé - OTC Markets 15:23:31 03/11/2023			Varia. 5j.	Varia. 1 janv.
0,0150 ^USD	-46,43%		-46,04%	-4,46%

04/03	TrivarX Limited annonce des changements au sein de sa direction	CI
24/02	TrivarX Limited publie ses résultats semestriels pour la période close au 31 décembre 2025	CI

Communiqués

14/07/22	Medibio : Notice of Extraordinary General Meeting/Proxy Form	PU
29/04/22	Medibio : Quarterly Update and Cashflow Report	PU
11/03/22	Medibio : Application for quotation of securities - MEB	PU
17/02/22	Medibio : Application for quotation of securities - MEB	PU
16/02/22	Medibio : Update - Proposed issue of securities - MEB	PU
31/01/22	Medibio : Quarterly Update and Cashflow Report	PU
20/01/22	Medibio : Entitlement Offer Document	PU
20/01/22	Medibio : Update - Proposed issue of securities - MEB	PU
18/01/22	Medibio : Notification regarding unquoted securities - MEB	PU
14/01/22	Medibio : Update - Proposed issue of securities - MEB	PU
19/12/21	Medibio : Application for quotation of securities - MEB	PU
15/12/21	Medibio : Investor Presentation December 2021	PU
15/12/21	Medibio : Proposed issue of securities - MEB	PU
09/12/21	Medibio : Application for quotation of securities - MEB	PU
30/10/18	Medibio Limited Quarterly ASX Update and Cashflows	GL
15/10/18	Receipt of $3,146,835 R&D Tax Incentive Refund	GL
08/10/18	Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 2018	GL
05/10/18	Medibio Provides Updated Company Presentation	GL
06/09/18	Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard	GL
29/08/18	Departure of Managing Director & Chief Executive Officer	GL
16/07/18	Medibio Submits FDA De Novo Application	GL
27/06/18	Peer-reviewed Neurology Publication on Medibio Science	GL
10/05/18	Medibio Announces Next Tranche of Corporate Health Contracts	GL
09/05/18	Medibio Corporate Health contract signed with Australia’s 3rd largest private healthcare provider	GL
12/04/18	Medibio finalizes acquisition of Vital Conversations	GL